Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 786, pseudogene (RN7SL786P)

Target
RN7SL786P
Molecular classification
Pseudogene, Non-coding RNA (derived)
01

Overview

RN7SL786P (RNA, 7SL, cytoplasmic 786, pseudogene) is a human genomic pseudogene derived from the sequence of the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP)[1][5][6][7]. It does not produce a functional product and is not considered a therapeutic target. RN7SL786P is a human pseudogene formed by the genomic integration of reverse transcribed RNA from the 7SL RNA gene. The 7SL RNA encodes the RNA component of the signal recognition particle (SRP), a ribonucleoprotein responsible for targeting secretory proteins to the endoplasmic reticulum[5][10]. Unlike functional 7SL RNA (e.g., RN7SL1), RN7SL786P is truncated and non-expressed due to sequence changes and lacks any protein-coding function[5][7][8]. Most 7SL pseudogenes appear to derive from various retrotransposition events and do not contribute to protein synthesis, receptor signaling, or transport processes. Though some pseudogenes can play regulatory roles, the available evidence indicates RN7SL786P is a non-functional element[4][5][8]. RN7SL786P is not a receptor, transporter, enzyme, or classical therapeutic target—rather, it is a pseudogene found in humans. There is nothing to suggest it is a valid drug target or that it plays a direct role in human disease or therapy[1][6][8].

Other names
RN7SL786P7SL pseudogene
02

Mechanism of action

Not applicable

03

Biological functions

None established; pseudogenes like RN7SL786P are nonfunctional copies of functional genes[8].Some pseudogenes may act as miRNA decoys (sponges) or produce siRNAs with regulatory effects, but there is no direct evidence for RN7SL786P specifically[4].
04

Disease associations

None directly attributed to RN7SL786PIn general, pseudogenes can have roles in gene regulation and may be involved in diseases if they act as miRNA sponges, but this is not demonstrated for RN7SL786P[4].

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 786, pseudogene (RN7SL786P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 786, pseudogene (RN7SL786P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call